Treace Medical Concepts, Inc. - stock earnings

TMCI Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
May 7, 2024 AfterMarket -0.30 / -0.31 - 51.1 million / 50.0 million -

TMCI Quarterly earnings

DateEarningsRevenue
2023Q4 -6.3 million USD 62.2 million USD
2023Q3 -17.5 million USD 40.8 million USD
2023Q2 -12.3 million USD 42.0 million USD
2023Q1 -13.1 million USD 42.2 million USD
2022Q4 -3.5 million USD 49.8 million USD
2022Q3 -12.9 million USD 33.1 million USD
2022Q2 -21.3 million USD 30.0 million USD
2022Q1 -10.0 million USD 29.0 million USD
2021Q4 -6.6 million USD 33.4 million USD
2021Q3 -6.4 million USD 21.6 million USD
2021Q2 -5.1 million USD 20.7 million USD
2021Q1 -2.4 million USD 18.7 million USD
2020Q4 2.6 million USD 24.1 million USD
2020Q3 -2.7 million USD 14.3 million USD
2020Q2 -2.0 million USD 7.7 million USD
2020Q1 -1.6 million USD 11.3 million USD

TMCI Yearly earnings

DateEarningsRevenue
2023 -49.5 million USD 187.1 million USD
2022 -47.3 million USD 141.8 million USD
2021 -24.6 million USD 94.4 million USD
2020 -6.4 million USD 57.4 million USD
2019 -5.1 million USD 39.4 million USD

TMCI

Price: $11.12

52 week price:
5.27
27.70

Earnings Per Share: -0.81 USD

P/E Ratio: -19.81

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Volume: 631400

Market Capitalization: 735.8 million

Links: